Advertisement
Skip to Content

Delaware Ivy Systematic Em Mkts Eq A IPOAX Fund Analysis

| Analyst rating as of | See Macquarie Investment Hub

Morningstar’s Analysis IPOAX

Will IPOAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Some reasons for optimism, but uncertainties remain.

Associate Director

Summary

|

Delaware Ivy Systematic Emerging Markets Equity has a new investment team, a new approach, and a new name. There are reasons for optimism, but the team has more to prove, keeping the Morningstar Analyst Rating at Neutral across share classes.

Unlock our full analysis with Morningstar Investor